Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2020 | B-cell ALL with IGH-IL3 rearrangement and eosinophilia

Andre Baruchel • 16 Jul 2020
EHA 2020
Acute Lymphoblastic Leukemia Leukemia

Andre Baruchel, MD, PhD, of Hôpital Robert Debre, Paris, France, reviews a rare B-cell acute lymphoblastic leukemia (ALL) IGH-IL3 rearrangement and associated eosinophilia. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Andre Baruchel

2:45
The need for alternative development pathways for CAR T-cell products
Andre Baruchel • 16 Feb 2024
4:16
The challenges with CAR T-cell therapy for T-ALL and the progress made to overcome these challenges
Andre Baruchel • 16 Feb 2024
4:06
CAR-T therapy in ALL: exploring dual-targeting of CD19 & CD22 to overcome resistance
Andre Baruchel • 16 Feb 2024
7:41
Tisagenlecleucel in pediatric R/R B-cell ALL
Andre Baruchel • 28 Jun 2020

Related Videos

2:06
Managing relapsed ALL: the role of novel cellular therapies & importance of conditioning regimens
Christina Peters • 15 Apr 2024
1:14
Promising novel agents in AML: menin inhibitors
Mark Levis • 16 Apr 2024
3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
1:48
Do all patients require maintenance therapy following alloSCT?
Mark Levis • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals